Last Updated: November 8, 2026

CLINICAL TRIALS PROFILE FOR SULFACETAMIDE SODIUM

« Back to Dashboard

All Clinical Trials for sulfacetamide sodium

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01369641 ↗	The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy	Terminated	Sidney Kimmel Cancer Center at Thomas Jefferson University	N/A	2011-08-24	This is a pilot, randomized, self-controlled study of the effects of intratympanic sodium thiosulfate (STS) on the degree of hearing loss in patients receiving cisplatin therapy. Sodium thiosulfate is an inactive ingredient contained in sulfacetamide ophthalmic solution which is used routinely as an otic solution delivered to the middle ear space. The hypothesis of this study is that local administration of sodium thiosulfate (STS) will result in improved hearing compared to ears not receiving the study drug in patients receiving systemic cisplatin therapy.
NCT06108193 ↗	Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris	Recruiting	Chang Gung Memorial Hospital	Phase 1/Phase 2	2023-07-11	Patients with acne vulgaris (AV) appeared to be a chronic inflammation with a wide range in teenagers and adult. The protocol design is as follows. The subjects enrolled through inclusion and exclusion criteria will undergo the blood and urine biochemical tests for baseline record. The photos from the subjects will be recorded per day, and the blood and urine biochemical tests will be recorded per week. Objectives: primary: to test the toxicity of topical minoxidil in treatment of acne vulgaris; second: to evaluate the response and disease control rate in this pilot study. Measurement: Time to resolution of individual acne lesions (14 days) Monitor of treatment efficacy: number of inflammatory acne lesions counting, time to resolution of individual acne lesion, and degree of acne severity measurement.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for sulfacetamide sodium

Condition Name

Chart
Table

Condition Name for sulfacetamide sodium
Intervention	Trials
Acne Vulgaris	1
Cancer	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for sulfacetamide sodium
Intervention	Trials
Acne Vulgaris	1
Hearing Loss	1
Deafness	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for sulfacetamide sodium

Trials by Country

Map
Table

Trials by Country for sulfacetamide sodium
Location	Trials
Taiwan	1
United States	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for sulfacetamide sodium
Location	Trials
Pennsylvania	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for sulfacetamide sodium

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for sulfacetamide sodium
Clinical Trial Phase	Trials
Phase 1/Phase 2	1
N/A	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for sulfacetamide sodium
Clinical Trial Phase	Trials
Recruiting	1
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for sulfacetamide sodium

Sponsor Name

Chart
Table

Sponsor Name for sulfacetamide sodium
Sponsor	Trials
Sidney Kimmel Cancer Center at Thomas Jefferson University	1
Chang Gung Memorial Hospital	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for sulfacetamide sodium
Sponsor	Trials
Other	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.